Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and effectiveness of a novel neoadjuvant treatment strategy
incorporating 5-fluorouracil/leucovorin with oxaliplatin ( FOLFOX )chemotherapy in
combination with chemo-radiation with gemcitabine.